Commentary Open Access
Volume 5 | Issue 3 | DOI: https://doi.org/10.33696/immunology.5.172
Fluoxetine is Antimicrobial and Modulates the Antibiotic Resistance Status of Bacteria
Alison M Mackay1,2,*
- 1Flex Clin Sci Ltd, Salford, UK
- 2Faculty of Biology, Medicine and Health, The University of Manchester, UK
Corresponding Author
Alison M Mackay, ynfdwas1@gmail.com
Received Date: July 28, 2023
Accepted Date: September 25, 2023
Mackay AM. Fluoxetine is Antimicrobial and Modulates the Antibiotic Resistance Status of Bacteria. J Cell Immunol. 2023;5(3):87-91.
Copyright: © 2023 Mackay AM. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords
Microbial resistance, Efflux pump inhibitors, Selective serotonin reuptake inhibitors, Innate immunity, Nosocomial infection, Catheter-associated urinary tract infection
Recommended Articles
M1 and M2 Macrophages Polarization via mTORC1 Influences Innate Immunity and Outcome of Ehrlichia Infection
Human monocytic ehrlichiosis (HME) is an emerging life-threatening tick-borne disease caused by the obligate intracellular bacterium Ehrlichia chaffeensis. HME is often presented as a nonspecific flu-like illness characterized by presence of fever, headache, malaise, and myalgia. However, in some cases the disease can evolve to a severe form, which is commonly marked by acute liver injury followed by multi-organ failure and toxic shock-like syndrome.
Microbial Resistance to Photodynamic Therapy
Microbial resistance to antibiotics has become a major area of research having caused over a million human deaths in 2019. At present, lower respiratory infection is the most burdensome disease. Antimicrobial Photodynamic Therapy (PDT) is regularly reported not to cause resistance in any pathogen, and to eradicate both microbes that are susceptible to antibiotics and those that are resistant.